Hyperspectral Imaging Articles & Analysis
3 news found
Based on its recent analysis of the North American Hyperspectral Retinal Imaging Industry, Frost & Sullivan recognizes Optina Diagnostics with the 2022 Technology Innovation Leadership Award for offering sophisticated artificial intelligence (AI)-powered Retinal Deep Phenotyping™ solutions. Optina Diagnostics’ comprehensive technology facilitates ...
Optina Diagnostics is committed to continue the development of its Retinal Deep Phenotyping Platform™, (https://bit.ly/30VgfE9) combining data-rich hyperspectral retinal imaging and artificial intelligence (AI) to better characterize brain health. In this new study, the Alzheimer Center Amsterdam team will evaluate the efficacy of the Mydriatic ...
Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its retinal imaging platform (CAPRS1/MHRC2). Optina Diagnostics’ platform uses Artificial Intelligence (AI) to analyze the data rich hyperspectral retinal images captured with the MHRC during a simple eye scan. ...